NuCana (NCNA) Income from Continuing Operations (2017 - 2025)

NuCana's (NCNA) quarterly Income from Continuing Operations came in at 3494346.6 in Q4 2025, down 244.62% year-on-year from 2416200.99 in Q4 2024, and down 313.68% quarter-over-quarter from 844700.7 in Q3 2025.

NuCana (NCNA) Income from Continuing Operations (2017 - 2025) Analysis & Trends

NuCana has disclosed Income from Continuing Operations across 9 years of filings, most recently posting 3494346.6 for Q4 2025.

  • Income from Continuing Operations for Q4 2025 came in at 3494346.6, down 244.62% year-over-year; the trailing twelve-month figure through Dec 2025 was 40505140.46 (down 41.62% YoY), and the FY2025 annual result was 38702233.89, down 59.38% from the prior year.
  • Income from Continuing Operations came in at 3494346.6 for Q4 2025 at NuCana, down from 844700.7 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 844700.7 in Q3 2025 to a low of 32606744.62 in Q2 2025.
  • The 5-year median for Income from Continuing Operations is 10382161.24 (2024), against an average of 11093411.51.
  • Across the five-year window, Income from Continuing Operations surged 90.89% in 2024 and sank 244.62% in 2025, its largest moves.
  • NuCana's Income from Continuing Operations stood at 21183986.69 in 2021, then climbed by 6.1% to 19891691.4 in 2022, then surged by 44.03% to 11133132.41 in 2023, then soared by 90.89% to 1013966.45 in 2024, then tumbled by 244.62% to 3494346.6 in 2025.
  • The last three Income from Continuing Operations figures came in at 3494346.6 (Q4 2025), 844700.7 (Q3 2025), and 32606744.62 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -26.94 Mn
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -2.97 Mn
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 30.80 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - -14.46 Mn
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -3.40 Mn
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -1.50 Mn
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 1.03 Bn
9 Abivax 94.26 Bn 94.26 Bn - -56.48 Mn
10 NuCana 29.13 Bn 29.13 Bn - -3.49 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -3.49 Mn
Sep 30, 2025 -844,700.70
Jun 30, 2025 -32.61 Mn
Mar 31, 2025 -3.56 Mn
Dec 31, 2024 -1.01 Mn
Sep 30, 2024 -6.82 Mn
Jun 30, 2024 -10.43 Mn
Mar 31, 2024 -10.33 Mn
Dec 31, 2023 -11.13 Mn
Sep 30, 2023 -10.26 Mn
Jun 30, 2023 -7.63 Mn
Mar 31, 2023 -10.77 Mn
Dec 31, 2022 -19.89 Mn
Sep 30, 2022 -7.04 Mn
Jun 30, 2022 -6.40 Mn
Mar 31, 2022 -14.00 Mn
Dec 31, 2021 -21.18 Mn
Sep 30, 2021 -13.72 Mn
Jun 30, 2021 -14.92 Mn
Mar 31, 2021 -15.81 Mn